TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34022949

Group type: EXPERIMENTAL
Intervention: Brief motivational interviewing via interactive instant-messaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: General health text-messages (comparator)
Number of subjects: 0
Study: 36056379

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the ISD model
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 150
Study: 33506399

Group type: EXPERIMENTAL
Intervention: SPIKES framework educational intervention (30-min didactic + refresher email)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 124
Study: 36145083

Group type: EXPERIMENTAL
Intervention: Arginine and leucine supplementation (ALs group, n = 20)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Supervised adapted physical activity program (APA group, n = 20)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Combination of arginine and leucine supplementation and supervised adapted physical activity program (ALs+APA group, n = 20)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 79
Study: 33245150

Group type: EXPERIMENTAL
Intervention: Time Out consultation (TOC) with the general practitioner (GP)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Time Out consultation (TOC) before treatment decision
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (no TOC)
Number of subjects: 154
Study: 35857296

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study: 33946984

Group type: EXPERIMENTAL
Intervention: Sit-stand desks intervention
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard desks (Control)
Number of subjects: 176
Study: 32144927

Group type: EXPERIMENTAL
Intervention: Contralateral needling therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine acupuncture treatment
Number of subjects: 62
Study: 35063278

Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg daily) and Letrozole (2.5 mg daily)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (200 mg daily alternating weeks) and Tamoxifen (20 mg twice daily)
Number of subjects: 74
Study: 35069071

Group type: EXPERIMENTAL
Intervention: Kegel exercises regimen (8 weeks, high-intensity, home-based)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extracorporeal magnetic stimulation (EMS) (2 sessions per week for 8 weeks)
Number of subjects: 0
Study: 34540784

Group type: EXPERIMENTAL
Intervention: Information-based health education and continuity of care intervention
Number of subjects: 116

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 116
Study: 33358124

Group type: EXPERIMENTAL
Intervention: FOLFIRI + Durvalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFIRI + Durvalumab and Tremelimumab
Number of subjects: 0
Study: 32112360

Group type: EXPERIMENTAL
Intervention: LAI aripiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: LAI paliperidone
Number of subjects: 0
Study: 36241853

Group type: EXPERIMENTAL
Intervention: 150 mg CBD
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 300 mg CBD
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: 600 mg CBD
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 34338408

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 400 mg
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Sotagliflozin 200 mg
Number of subjects: 277
Study: 32157294

Group type: EXPERIMENTAL
Intervention: Choice grade steaks on day 9
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Select grade steaks on day 9
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Proximal location steaks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Middle location steaks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Distal location steaks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All steaks analyzed for metmyoglobin reducing ability (MRA) and oxygen consumption (OC)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Type I, IIA, and IIX fibers
Number of subjects: 21
Study: 34544526

Group type: EXPERIMENTAL
Intervention: CCRT plus Endostar (CCRT+E arm)
Number of subjects: 116

Group type: COMPARATOR
Intervention: CCRT alone (CCRT arm)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: CCRT plus Endostar (CCRT+E arm) with positive VEGFR2 expression
Number of subjects: 116

Group type: COMPARATOR
Intervention: CCRT alone (CCRT arm) with positive VEGFR2 expression
Number of subjects: 116
Study: 32384462

Group type: EXPERIMENTAL
Intervention: Portable oxygen concentrator with an auto‐DODS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous‐flow oxygen concentrator
Number of subjects: 20
Study: 34971651

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 126
Study: 32150750

Group type: EXPERIMENTAL
Intervention: A-FLU-v (adjuvanted)
Number of subjects: 175

Group type: COMPARATOR
Intervention: NA-FLU-v (nonadjuvanted)
Number of subjects: 175
Study: 34400570

Group type: EXPERIMENTAL
Intervention: Health warning label theme: harming family or children with secondhand smoke
Number of subjects: 3247

Group type: EXPERIMENTAL
Intervention: Health warning label theme: self-harm from using cigarettes
Number of subjects: 3247

Group type: EXPERIMENTAL
Intervention: Health warning label theme: reinforcing compliance with existing smoke-free policies
Number of subjects: 3247

Group type: EXPERIMENTAL
Intervention: Health warning label theme: anticigarette gift giving practices
Number of subjects: 3247
Study: 33895882

Group type: EXPERIMENTAL
Intervention: Conbercept
Number of subjects: 160

Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Conbercept and Ranibizumab
Number of subjects: 160
Study: 32682697

Group type: EXPERIMENTAL
Intervention: eGFRDiff (calculated as eGFRcys − eGFRcr)
Number of subjects: 9092

Group type: EXPERIMENTAL
Intervention: eGFRDiff
Number of subjects: 9092
Study: 34806530

Group type: EXPERIMENTAL
Intervention: Voice rehabilitation (10 sessions immediately following completion of radiotherapy)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no voice rehabilitation)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Voice rehabilitation (10 sessions)
Number of subjects: 74
Study: 34702188

Group type: EXPERIMENTAL
Intervention: Oseltamivir plus standard of care
Number of subjects: 691

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 691
Study: 33021455

Group type: EXPERIMENTAL
Intervention: Ketamine-midazolam (KM)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Alfaxalone-midazolam (AM)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Flumazenil (0.05 mg/kg SC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Both sedation protocols
Number of subjects: 9
Study: 35964045

Group type: EXPERIMENTAL
Intervention: Urotherapy with the SENS-U added for 3 consecutive weeks
Number of subjects: 480

Group type: COMPARATOR
Intervention: Urotherapy with a SHAM device for 3 weeks
Number of subjects: 480

Group type: COMPARATOR
Intervention: Urotherapy (care as usual)
Number of subjects: 480
Study: 33499676

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Travoprost 0.004%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Tafluprost 0.0015%
Number of subjects: 60
Study: 35051648

Group type: EXPERIMENTAL
Intervention: Low FODMAP–gluten‐free diet
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual gluten‐free diet
Number of subjects: 70
Study: 34530886

Group type: EXPERIMENTAL
Intervention: Four-factor prothrombin complex concentrate (PCC) 1 mL/kg (25 IU/ml of Factor IX/Kg) within 1-h post-admission
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline solution 0.9% as a placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four-factor prothrombin complex concentrate (PCC)
Number of subjects: 0
Study: 32640755

Group type: EXPERIMENTAL
Intervention: Nasal breathing with FeelBreathe (FB) device
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oronasal breathing
Number of subjects: 18
Study: 34615719

Group type: EXPERIMENTAL
Intervention: Lacnotuzumab + gemcitabine + carboplatin (gem-carbo)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Gemcitabine + carboplatin (gem-carbo)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lacnotuzumab + gem-carbo
Number of subjects: 49

Group type: COMPARATOR
Intervention: Gem-carbo
Number of subjects: 49
Study: 35061598

Group type: EXPERIMENTAL
Intervention: Scarf osteotomy with additional Akin correction
Number of subjects: 145

Group type: COMPARATOR
Intervention: Scarf osteotomy without additional Akin correction
Number of subjects: 145
Study: 33221428

Group type: EXPERIMENTAL
Intervention: Remnant-tensioning single-bundle (RT-SB) ACL reconstruction
Number of subjects: 67

Group type: COMPARATOR
Intervention: Double-bundle (DB) ACL reconstruction
Number of subjects: 67
Study: 33053823

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50 IU/kg body mass)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 31
Study: 35279289

Group type: EXPERIMENTAL
Intervention: del Nido cardioplegia
Number of subjects: 474

Group type: COMPARATOR
Intervention: cold blood cardioplegia
Number of subjects: 474
Study: 33934982

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) oxygen therapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional oxygen therapy through a simple oxygen mask
Number of subjects: 200
Study: 32560744

Group type: EXPERIMENTAL
Intervention: Candidate agents for COVID-19 treatment (specific candidates not detailed)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 16
Study: 35015750

Group type: EXPERIMENTAL
Intervention: TRV‐chair
Number of subjects: 74

Group type: COMPARATOR
Intervention: Manual treatment maneuvers
Number of subjects: 74
Study: 34279996

Group type: EXPERIMENTAL
Intervention: Genetically predicted plasma Lp(a) levels
Number of subjects: 408403

Group type: EXPERIMENTAL
Intervention: Genetically predicted LPA expression levels
Number of subjects: 408403
Study: 34619115

Group type: EXPERIMENTAL
Intervention: Nurse-led transition intervention program (1-hour individualized session with a cardiology nurse)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 33181655

Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA) and multi-disciplinary management including rehabilitation exercise, diet adjustment, multi-drug evaluation, acupoint massage in TCM, and patient education for 12 months
Number of subjects: 320

Group type: COMPARATOR
Intervention: Routine management for basic diseases
Number of subjects: 320
Study: 35553967

Group type: EXPERIMENTAL
Intervention: 50g prunes/day
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 100g prunes/day
Number of subjects: 106

Group type: COMPARATOR
Intervention: 0g prunes/day (control)
Number of subjects: 106
Study: 33228550

Group type: EXPERIMENTAL
Intervention: Occipital 10 Hz rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 18
Study: 35272599

Group type: EXPERIMENTAL
Intervention: COVID‐19 vaccine (CoronaVac)
Number of subjects: 101
Study: 34401364

Group type: EXPERIMENTAL
Intervention: blended CBT (bCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: face-to-face CBT (ftf CBT)
Number of subjects: 0
Study: 36459828

Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 382
Study: 32942920

Group type: EXPERIMENTAL
Intervention: Ultrasound Biomicroscopy (Quantel Aviso with 50 MHz transducer)
Number of subjects: 15
Study: 34981712

Group type: EXPERIMENTAL
Intervention: Lung transplant recipients
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy volunteers (Control group)
Number of subjects: 34
Study: 33421840

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 101
Study: 32585226

Group type: EXPERIMENTAL
Intervention: Oxygen administration (10 L/min by face mask)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Room air
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Oxygen administration
Number of subjects: 114
Study: 35386031

Group type: EXPERIMENTAL
Intervention: Prenatal depressive symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postpartum depressive symptoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unmarried status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenatal substance use (smoking or alcohol consumption)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risk factors for postpartum depression
Number of subjects: 0
Study: 33835071

Group type: EXPERIMENTAL
Intervention: Group X (flared crest module and buttress thread design)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group A (parallel crest module and V-shaped thread design)
Number of subjects: 40
Study: 32963294

Group type: EXPERIMENTAL
Intervention: Omega-3-PUFA enriched chicken-meat and eggs
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control chicken-meat and eggs
Number of subjects: 161
Study: 35770251

Group type: EXPERIMENTAL
Intervention: QazCovid-in® vaccine (5 μg each, 2 doses, 21 days apart)
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: QazCovid-in® vaccine
Number of subjects: 3000
Study: 33855996

Group type: EXPERIMENTAL
Intervention: Aromatherapy and foot reflexology added to standard of care
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard of care management during brachytherapy
Number of subjects: 41
Study: 36089374

Group type: EXPERIMENTAL
Intervention: Piezosurgery (PI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Turbine handpiece (TH)
Number of subjects: 80
Study: 32386922

Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First drug administration
Number of subjects: 0
Study: 36054046

Group type: EXPERIMENTAL
Intervention: Nonablative fractional 1,550-nm erbium:glass laser (NAFL)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Radiofrequency microneedling (RFMN)
Number of subjects: 21
Study: 34759559

Group type: EXPERIMENTAL
Intervention: Intraperitoneal nebulization with 4 ml of 0.75% ropivacaine (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intraperitoneal nebulization with 4 ml of saline (Group C)
Number of subjects: 40
Study: 36333692

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (5000 units weekly for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32311349

Group type: EXPERIMENTAL
Intervention: Biomass-fueled cookstove intervention
Number of subjects: 1805

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1805
Study: 36106548

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (S/V) treatment
Number of subjects: 8787

Group type: EXPERIMENTAL
Intervention: Restricted sacubitril/valsartan (rS/V) treatment
Number of subjects: 8787

Group type: COMPARATOR
Intervention: Conventional HF treatment (non-S/V)
Number of subjects: 8787

Group type: EXPERIMENTAL
Intervention: Overall mortality rate
Number of subjects: 8787

Group type: EXPERIMENTAL
Intervention: HF hospitalizations
Number of subjects: 8787

Group type: EXPERIMENTAL
Intervention: Emergency room visits without hospitalization
Number of subjects: 8787
Study: 32976864

Group type: EXPERIMENTAL
Intervention: L-GrAFT7 risk score
Number of subjects: 3423

Group type: EXPERIMENTAL
Intervention: L-GrAFT7 risk score (highest tertile)
Number of subjects: 3423
Study: 32221696

Group type: EXPERIMENTAL
Intervention: NIC 18.7 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC 10.8 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC 5.3 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC 2.3 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC 1.3 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC ≤ 2.3 mg/g
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: NIC ≥ 5.3 mg/g
Number of subjects: 17
Study: 34919072

Group type: EXPERIMENTAL
Intervention: Multiscale pyramid two-dimensional convolutional neural network for automated segmentation
Number of subjects: 20
Study: 35896533

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE) with D-cycloserine (DCS)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Prolonged Imaginal Exposure (PE) with D-cycloserine (DCS)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 32584196

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue recipe (BHR)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bushen Huoxue recipe (BHR) combined with estradiol valerate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BHR in rats with kidney deficiency-related blood stasis
Number of subjects: 60
Study: 35147131

Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii multiglycosides tablets (1-1.5 mg/kg body weight/d, orally) in addition to angiotensin converting enzyme inhibitor/angiotensin receptor blocker
Number of subjects: 20

Group type: COMPARATOR
Intervention: Angiotensin converting enzyme inhibitor/angiotensin receptor blocker
Number of subjects: 20
Study: 33328115

Group type: EXPERIMENTAL
Intervention: Gabby intervention (online conversational agent)
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control group (letter listing preconception risks)
Number of subjects: 528
Study: 35300759

Group type: EXPERIMENTAL
Intervention: Deep learning-based risk prediction model combining pre/intraoperative risk factors and intraoperative vital signs; evaluated using logistic regression analysis and LSTM model.
Number of subjects: 839

Group type: EXPERIMENTAL
Intervention: Simulated annealing algorithm to adjust intraoperative vital signs.
Number of subjects: 839

Group type: COMPARATOR
Intervention: Multivariable Logistic regression model, random forest model, and LSTM model including vital signs only.
Number of subjects: 839
Study: 35534435

Group type: EXPERIMENTAL
Intervention: Electronic nose for prostate cancer diagnosis
Number of subjects: 174
Study: 33197657

Group type: EXPERIMENTAL
Intervention: Selenium (200 ng) + Vitamin E (400 IU)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32171422

Group type: EXPERIMENTAL
Intervention: Rifampicin 10 mg/kg plus clarithromycin 15 mg/kg extended release once daily for 8 weeks (RC8)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Rifampicin 10 mg/kg plus intramuscular streptomycin 15 mg/kg once daily for 8 weeks (RS8)
Number of subjects: 310
Study: 34895993

Group type: EXPERIMENTAL
Intervention: ACDF surgery with bony endplates preserved (Group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ACDF surgery with bony endplates removed (Group B)
Number of subjects: 0
Study: 34619574

Group type: EXPERIMENTAL
Intervention: Active rTMS (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham rTMS (n=10)
Number of subjects: 20
Study: 33292423

Group type: EXPERIMENTAL
Intervention: Participatory intervention to improve job satisfaction of general practice teams
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35324230

Group type: EXPERIMENTAL
Intervention: Web‐PE (Web‐based Prolonged Exposure Therapy)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Present‐Centered Therapy (PCT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: PCT (Present‐Centered Therapy)
Number of subjects: 74
Study: 616389173

Group type: EXPERIMENTAL
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conservative treatment (CT)
Number of subjects: 80
Study: 35785889

Group type: EXPERIMENTAL
Intervention: Mepolizumab
Number of subjects: 1
Study: 34880973

Group type: EXPERIMENTAL
Intervention: Endoscopic examination combined with ultrasound imaging based on intelligent algorithm processing (Cascade RCNN model algorithm)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Simple use of endoscopy (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Traditional convolutional neural network (CNN) model
Number of subjects: 80
Study: 35723120

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS combined with FES
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-frequency rTMS
Number of subjects: 60

Group type: COMPARATOR
Intervention: FES
Number of subjects: 60
Study: 33709134

Group type: EXPERIMENTAL
Intervention: Water Insecurity (WI)
Number of subjects: 716
Study: 33121439

Group type: EXPERIMENTAL
Intervention: Direct acting antiviral (DAA) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medication adherence monitoring and quality of life assessments using validated self-reported instruments (EQ-5D-5L)
Number of subjects: 0
Study: 36455222

Group type: EXPERIMENTAL
Intervention: Modified cap‐assisted endoscopic mucosal resection (mEMR-C)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Endoscopic submucosal dissection (ESD)
Number of subjects: 79
Study: 33168393

Group type: EXPERIMENTAL
Intervention: Type 1 diabetes
Number of subjects: 1385

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 1385
Study: 36482599

Group type: EXPERIMENTAL
Intervention: Sublingual Immunotherapy with Dermatophagoides Farinae Drops for 3 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mometasone Furoate nasal spray for 3 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sublingual Immunotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Mometasone Furoate nasal spray
Number of subjects: 60
Study: 33081570

Group type: EXPERIMENTAL
Intervention: Dexrazoxane plus epirubicin
Number of subjects: 2945

Group type: EXPERIMENTAL
Intervention: Doxorubicin and epirubicin
Number of subjects: 2945

Group type: EXPERIMENTAL
Intervention: ACEIs plus doxorubicin
Number of subjects: 2945
Study: 32272345

Group type: EXPERIMENTAL
Intervention: Optimised end-to-end CNN architecture for segmentation
Number of subjects: 947